Tirzepatide
Where innovation meets wellness.
The next big thing.
Prism Medical provides tirzepatide weight loss therapy expertise in our office in Rancho Mirage, CA.
Read on to learn about tirzepatide and how it can help you reach your weight goal.
Benefits + Effects
-
Tirzepatide has shown impressive efficacy in lowering blood glucose levels. Clinical trials have demonstrated that it can significantly reduce HbA1c (a marker of long-term blood glucose control), often more effectively than other diabetes medications. This improved glycemic control helps in reducing the risk of diabetes-related complications, such as cardiovascular disease and neuropathy.
-
In addition to controlling blood sugar, tirzepatide has been associated with substantial weight loss in patients. This is particularly beneficial for individuals with type 2 diabetes, as obesity is a common comorbidity. Weight loss contributes to better overall health, reducing the risk of additional health issues such as hypertension, sleep apnea, and joint problems.
-
Tirzepatide has shown potential cardiovascular benefits beyond its primary role in diabetes management. Studies suggest that it may help in reducing the risk of cardiovascular events, such as heart attack and stroke. These benefits are likely due to its effects on weight reduction, blood pressure, and lipid profile improvements, contributing to overall cardiovascular health.
FAQs
-
Semaglutide and tirzepatide are both medications used in the treatment of type 2 diabetes, but they belong to different classes of drugs and have distinct mechanisms of action. Here are the differences between semaglutide and tirzepatide:
Drug Class:
Semaglutide: Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the action of GLP-1, a hormone that stimulates insulin release and reduces glucagon secretion.
Tirzepatide: Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. It activates both GIP and GLP-1 receptors to stimulate insulin release and reduce glucagon secretion.
Mode of Action:
Semaglutide: Semaglutide primarily acts on GLP-1 receptors to increase insulin secretion from pancreatic beta cells, reduce glucagon secretion from pancreatic alpha cells, slow down gastric emptying, and promote satiety.
Tirzepatide: Tirzepatide targets both GIP and GLP-1 receptors. By activating these receptors, it enhances insulin secretion, inhibits glucagon release, slows gastric emptying, and promotes satiety. The dual action on both GIP and GLP-1 receptors potentially provides greater glycemic control compared to drugs targeting only GLP-1 receptors.
Clinical Trials:
Semaglutide: Semaglutide has been extensively studied and approved in various formulations, including once-weekly subcutaneous injections (Ozempic) and oral tablets (Rybelsus). In clinical trials, it has shown efficacy in reducing HbA1c levels, promoting weight loss, and improving cardiovascular outcomes.
Tirzepatide: Tirzepatide is a newer medication with promising clinical trial results and recently received FDA approval.
-
Tirzepatide helps manage blood sugar by mimicking natural hormones that increase insulin release and reduce glucose production. It also curbs appetite, leading to weight loss. Together, these actions make it easier to control diabetes and improve overall health.
-
In clinical studies, patients on tirzepatide therapy have shown significant weight loss. On average, individuals can lose between 12% and 22.5% of their body weight, depending on the dosage used and the duration of the treatment. For example, a person weighing 200 pounds might lose approximately 24 to 45 pounds.
See what you’re made of.
Tirzepatide appointments include an InBody 770 analysis, which is used by major hospitals and provides essential weight loss data, such as Percent Body Fat, Skeletal Muscle Mass, and Body Mass Ratio. Your weight is made up of muscle, fat, and water. The key to effective weight loss is losing excess body fat, not overall body weight. Weight loss is not the same as fat loss. Instead of tracking how heavy you are, use the body composition analysis to track how healthy you truly are.
Featuring
Featuring
Want to take your GLP-1 journey to the next level? Upgrade your experience with a Continuous Glucose Monitor by Stelo to get real-time feedback for real-life results. Ask for it in office!
How to start
-
COMPLETE ELIGIBILITY FORM
Complete our brief eligibility form so we can confirm that care is available and direct you to the appropriate first appointment.
-
SCHEDULE & PREPAY
Eligible patients will be directed immediately to schedule either a telemedicine or in-person new-patient visit. The $275 visit fee is prepaid when booking. This fee does not include medication costs.
-
COMPLETE PATIENT FORMS
After scheduling, you’ll receive instructions to complete your medical history and required paperwork before your visit with Dr. Buckle.